Beam Therapeutics BEAM Equity Method Investment, Realized Gain (Loss) on Disposal
Equity Method Investment, Realized Gain (Loss) on Disposal at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal.
The official record: Beam Therapeutics’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's equity method investment, realized gain (loss) on disposal.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's equity method investment, realized gain (loss) on disposal?
- Beam Therapeutics (BEAM) reported equity method investment, realized gain (loss) on disposal of $63.79M in Q4 2025.
- What does equity method investment, realized gain (loss) on disposal mean?
- Captures the realized gains or losses recognized upon the sale or disposal of investments accounted for under the equity method. This metric reflects the success of the company's strategic minority investments in other entities. It serves as a measure of capital allocation efficiency regarding non-core business holdings.